HighPoint Advisor Group LLC bought a new position in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 3,235 shares of the company’s stock, valued at approximately $507,000.

A number of other large investors also recently made changes to their positions in the company. Signaturefd LLC boosted its stake in Thermo Fisher Scientific by 10.6% in the second quarter. Signaturefd LLC now owns 842 shares of the company’s stock valued at $124,000 after buying an additional 81 shares in the last quarter. Tiemann Investment Advisors LLC boosted its position in shares of Thermo Fisher Scientific by 10.2% in the first quarter. Tiemann Investment Advisors LLC now owns 1,625 shares of the company’s stock valued at $230,000 after buying an additional 150 shares during the period. Catawba Capital Management VA boosted its position in shares of Thermo Fisher Scientific by 9.3% in the second quarter. Catawba Capital Management VA now owns 1,642 shares of the company’s stock valued at $243,000 after buying an additional 140 shares during the period. Wedbush Securities Inc. boosted its position in shares of Thermo Fisher Scientific by 4.0% in the second quarter. Wedbush Securities Inc. now owns 1,656 shares of the company’s stock valued at $245,000 after buying an additional 64 shares during the period. Finally, Alpha Windward LLC boosted its position in shares of Thermo Fisher Scientific by 21.3% in the second quarter. Alpha Windward LLC now owns 1,836 shares of the company’s stock valued at $271,000 after buying an additional 322 shares during the period. 87.47% of the stock is owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at 150.05 on Monday. The firm’s 50-day moving average price is $153.94 and its 200-day moving average price is $148.48. Thermo Fisher Scientific Inc. has a one year low of $117.10 and a one year high of $160.68. The company has a market cap of $59.16 billion, a PE ratio of 30.02 and a beta of 1.00.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, July 28th. The company reported $2.03 earnings per share for the quarter, beating analysts’ consensus estimates of $2.01 by $0.02. The firm earned $4.54 billion during the quarter, compared to the consensus estimate of $4.50 billion. Thermo Fisher Scientific had a return on equity of 14.70% and a net margin of 11.35%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.84 EPS. On average, equities research analysts forecast that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.40%. Thermo Fisher Scientific’s dividend payout ratio is currently 12.02%.

Several research analysts recently commented on TMO shares. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $175.00 target price for the company in a research report on Wednesday, July 20th. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research report on Wednesday, July 6th. Leerink Swann reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research report on Sunday, May 29th. Mizuho raised their target price on Thermo Fisher Scientific from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, May 27th. Finally, Citigroup Inc. raised their target price on Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a research report on Friday, July 29th. Three investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $159.66.

In related news, insider Thomas W. Loewald sold 913 shares of the company’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $151.92, for a total transaction of $138,702.96. Following the completion of the sale, the insider now directly owns 39,983 shares in the company, valued at approximately $6,074,217.36. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director C Martin Harris sold 390 shares of the company’s stock in a transaction on Friday, August 5th. The stock was sold at an average price of $157.33, for a total value of $61,358.70. Following the sale, the director now owns 4,648 shares of the company’s stock, valued at $731,269.84. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.